Literature DB >> 24652958

Lymphocytosis and ibrutinib treatment of CLL.

Davide Rossi1, Gianluca Gaidano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24652958     DOI: 10.1182/blood-2014-01-549493

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Evolution of ibrutinib resistance in chronic lymphocytic leukemia (CLL).

Authors:  Natalia L Komarova; Jan A Burger; Dominik Wodarz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-08       Impact factor: 11.205

Review 2.  International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).

Authors:  A Younes; P Hilden; B Coiffier; A Hagenbeek; G Salles; W Wilson; J F Seymour; K Kelly; J Gribben; M Pfreunschuh; F Morschhauser; H Schoder; A D Zelenetz; J Rademaker; R Advani; N Valente; C Fortpied; T E Witzig; L H Sehn; A Engert; R I Fisher; P-L Zinzani; M Federico; M Hutchings; C Bollard; M Trneny; Y A Elsayed; K Tobinai; J S Abramson; N Fowler; A Goy; M Smith; S Ansell; J Kuruvilla; M Dreyling; C Thieblemont; R F Little; I Aurer; M H J Van Oers; K Takeshita; A Gopal; S Rule; S de Vos; I Kloos; M S Kaminski; M Meignan; L H Schwartz; J P Leonard; S J Schuster; V E Seshan
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

3.  Management of atypical chronic lymphocytic leukemia presenting with extreme leukocytosis.

Authors:  Ramya Muddasani; Neel Talwar; Jaime Andres Suarez-Londono; Marc Braunstein
Journal:  Clin Case Rep       Date:  2020-03-05

Review 4.  Role of NFAT in Chronic Lymphocytic Leukemia and Other B-Cell Malignancies.

Authors:  Ilenia Sana; Maria Elena Mantione; Piera Angelillo; Marta Muzio
Journal:  Front Oncol       Date:  2021-04-01       Impact factor: 6.244

5.  YouTube as a platform to better understand the treatment of lymphoma using ibrutinib: a cross-sectional study.

Authors:  Lin Yang; Xiuliang Qiu; Qiuling Zhao; Hongqiang Qiu; Yu Cheng; Wenbin Liu; Ruixiang Xie
Journal:  Ann Transl Med       Date:  2022-08

6.  A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia.

Authors:  Jared A Cohen; Francesca Maria Rossi; Antonella Zucchetto; Riccardo Bomben; Lodovico Terzi-di-Bergamo; Kari G Rabe; Massimo Degan; Agostino Steffan; Jerry Polesel; Enrico Santinelli; Idanna Innocenti; Giovanna Cutrona; Giovanni D'Arena; Gabriele Pozzato; Francesco Zaja; Annalisa Chiarenza; Davide Rossi; Francesco Di Raimondo; Luca Laurenti; Massimo Gentile; Fortunato Morabito; Antonino Neri; Manlio Ferrarini; Christopher D Fegan; Christopher J Pepper; Giovanni Del Poeta; Sameer A Parikh; Neil E Kay; Valter Gattei
Journal:  Haematologica       Date:  2019-10-03       Impact factor: 9.941

Review 7.  Ibrutinib in primary central nervous system diffuse large B-cell lymphoma.

Authors:  Justin T Low; Katherine B Peters
Journal:  CNS Oncol       Date:  2020-03-06

8.  Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review.

Authors:  Zemene Demelash Kifle
Journal:  Metabol Open       Date:  2021-07-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.